Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Antiphospholipid Syndrome Antiphospholipid antibodies can induce endothelial-cell,
complement, platelet, neutrophil, and monocyte activation, leading to thrombosis, renal …

Objectives Develop recommendations for women9s health issues and family planning in
systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Methods …

Tumor necrosis factor-α (TNF-α) is a central regulator of inflammation, and TNF-α
antagonists may be effective in treating inflammatory disorders in which TNF-α plays a major …

Background Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is
caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2 glycoprotein-I …

Objective To identify and assess the magnitude of effect of pregnancy outcome predictors in
women with antiphospholipid syndrome (APS) by means of systematic review and meta …

In European multicenter study, we aimed to describe the real-life hydroxychloroquine use in
APS patients during pregnancy and determine its benefit in refractory obstetrical APS. We …

Recurrent thrombosis and miscarriages are the main clinical manifestations of
antiphospholipid syndrome (APS). Although most patients display both clinical signs, some …

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with a
high prevalence in females of childbearing age. Pregnancy in SLE nowadays has favorable …

Objective We previously reported that lupus anticoagulant (LAC) is the main predictor of
poor pregnancy outcome in antiphospholipid antibody (aPL)-positive patients. We sought to …